Institut Guttmann   Report issue

Academic/Hospital Phase 2
Founded: Barcelona Spain (1965)

Organization Overview

First Clinical Trial
2014
NCT02705950
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital de Neurorehabilitació Institut Guttmann | Institut Guttmann | Macarena Gil

Active Ingredients

Drugs in Phase 2 Trials (1)

wharton's jelly mesenchymal stem cells (2 trials)

Drugs in Other Trials (1)

baclofen (lioresal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Spinal Cord Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2